Lifevantage PE Ratio 2010-2022 | LFVN

Current and historical p/e ratio for Lifevantage (LFVN) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lifevantage PE ratio as of March 24, 2023 is 29.17.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Lifevantage PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2023-03-24 3.53 0.00
2022-12-31 3.69 $-0.05 0.00
2022-09-30 3.69 $0.04 92.29
2022-06-30 4.25 $0.24 17.71
2022-03-31 4.62 $0.70 6.59
2021-12-31 6.13 $0.73 8.40
2021-09-30 6.57 $0.98 6.70
2021-06-30 7.13 $0.90 7.92
2021-03-31 9.07 $0.81 11.19
2020-12-31 9.04 $0.80 11.30
2020-09-30 11.70 $0.84 13.93
2020-06-30 13.11 $0.79 16.60
2020-03-31 9.99 $0.79 12.64
2019-12-31 15.14 $0.80 18.92
2019-09-30 13.29 $0.56 23.72
2019-06-30 12.59 $0.50 25.17
2019-03-31 13.86 $0.45 30.79
2018-12-31 12.79 $0.45 28.42
2018-09-30 10.66 $0.41 25.99
2018-06-30 6.18 $0.41 15.07
2018-03-31 3.50 $0.21 16.67
2017-12-31 4.62 $0.09 51.29
2017-09-30 4.09 $0.09 45.47
2017-06-30 4.20 $0.11 38.17
2017-03-31 5.21 $0.26 20.03
2016-12-31 7.90 $0.33 23.95
2016-09-30 9.17 $0.42 21.84
2016-06-30 13.19 $0.42 31.40
2016-03-31 8.82 $0.26 33.94
2015-12-31 9.23 $0.26 35.51
2015-09-30 5.50 $0.22 24.99
2015-06-30 3.60 $0.49 7.34
2015-03-31 5.36 $0.63 8.51
2014-12-31 8.82 $0.70 12.61
2014-09-30 7.74 $0.84 9.21
2014-06-30 9.77 $0.70 13.97
2014-03-31 8.89 $0.56 15.88
2013-12-31 11.20 $0.63 17.79
2013-09-30 16.16 $0.42 38.48
2013-06-30 15.75 $0.42 37.51
2013-03-31 15.95 $0.70 22.79
2012-12-31 14.87 $0.14 106.18
2012-09-30 23.28 $0.49 47.53
2012-06-30 19.21 $0.42 45.74
2012-03-31 25.52 $-3.78 0.00
2011-12-31 9.71 $-4.34 0.00
2011-09-30 10.18 $-4.27 0.00
2011-06-30 10.18 $-4.34 0.00
2011-03-31 4.82 $-0.98 0.00
2010-12-31 2.65 $-1.05 0.00
2010-09-30 3.39 $-1.54 0.00
2010-06-30 3.46 $-1.47 0.00
2010-03-31 2.65 $-1.68 0.00
2009-12-31 1.70 $-1.54 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.045B $0.206B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.830B 20.65
McKesson (MCK) United States $46.809B 13.88
AmerisourceBergen (ABC) United States $31.035B 13.76
West Pharmaceutical Services (WST) United States $24.430B 38.38
Laboratory Of America Holdings (LH) United States $19.204B 10.91
Cardinal Health (CAH) United States $18.019B 13.93
Cooper (COO) United States $17.039B 28.52
CONMED (CNMD) United States $2.954B 36.54